Clinical outcomes of adolescents and young adults in adult HIV care

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 2, 2011, Pages 193-197

  Ryscavage, Patrick A ^a   Anderson, Evan J ^a   Sutton, Sarah H ^a   Reddy, Susheel ^a   Taiwo, Babafemi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

adolescents; African American; HIV; virologic suppression; young adults

Indexed keywords

ADOLESCENT; ADOLESCENT HEALTH; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD HEALTH CARE; CONTROLLED STUDY; ETHNICITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 85027922132     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0B013E31822D7564     Document Type: Article

References (37)

1. Campsmith ML, Rhodes PH, Hall HI, et al. Undiagnosed HIV prevalence among adults and adolescents in the United States at the end of 2006. J Acquir Immune Defic Syndr. 2010;53:619-624.
2. Torian L, Chen M, Rhodes P, et al. HIV Surveillance-United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60:689-693.
3. Hall HI, Ruiguang S, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529.
4. STI/HIV Chicago Surveillance Report 2010. Chicago Department of Public Health. Available at: http://www.cityofchicago.org/content/dam/city/-depts/cdph/ infectious-disease/STI-HIV-AIDS/STIHIVChicago-Fall2010a.pdf. Accessed January 13, 2011.
5. Valenzuela JM, Buchanan CL, Radcliffe J, et al. Transition to adult services among behaviorally infected adolescents with HIV-a qualitative study. J Pediatr Psychol. 2011;36:134-140.
6. Rudy BJ, Lindsey JC, Flynn PM, et al. Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort. AIDS Res Hum Retroviruses. 2006;22:213-221.
7. Ding H, Wilson CM, Modjarrad K, et al. Predictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project. Arch Pediatr Adolesc Med. 2009;163:1100-1105.
8. Rhee SY, Gonzales MJ, Kantor R, et al. Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res. 2003;31:298-303. (Pubitemid 36150389)
9. Haahr M. True random number service. Available at: http://www.random. org/nform.html. Accessed May 17, 2010.
10. Wilson CM, Houser J, Partlow C, et al. The REACH (Reaching for Excellence in Adolescent Care and Health) project: study design, methods, and population profile. J Adolesc Health. 2001;29:8-18. (Pubitemid 32799155)
11. Stanford PD, Monte DA, Briggs FM, et al. Reaching for Excellence in Adolescent Care and Health Project. Recruitment and retention of adolescent participants in HIV research: findings from the REACH (Reaching for Excellence in Adolescent Care and Health) Project. J Adolesc Health. 2003;32:192-203. (Pubitemid 36279404)
12. Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51:65-71.
13. Flynn PM, Rudy BJ, Lindsey JC, et al. Long-term observation of adolescents initiating HAART therapy: three-year follow-up. AIDS Res Hum Retroviruses. 2007;23:1208-1214. (Pubitemid 350014760)
14. Sabin C. The COHERE study. Response to combination ART: variation by age [528]. Presented at: 14th Conference on Retroviruses and Opportunistic Infections; February 25-28, 2007; Los Angeles, CA.
15. Rogers AS, Futterman DK, Moscicki AB, et al. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: design, methods, and selected characteristics of participants. J Adolesc Health. 1998; 22:300-311. (Pubitemid 28163251)
16. Oramasionwu CU, Brown CM, Ryan L, et al. HIV/AIDS disparities: the mounting epidemic plaguing US blacks. J Natl Med Assoc. 2009;101: 1196-1204.
17. Stang J, Story M, eds. Guidelines for Adolescent Nutrition Services. Minneapolis, MN: University of Minnesota Press; 2005.
18. Garcia J. Adolescents with HIV: engagement and treatment challenges. Presented at: 12th Annual Clinical Conference for the Ryan White HIV/AIDS; October 15-17, 2009; Dallas, TX.
19. Foster C, Waelbrouck A, Peltier A. Adolescents and HIV infection. Curr Opin HIV AIDS. 2007;2:431-436. (Pubitemid 47254740)
20. Martinez J, Hosek SG, Carleton RA. Screening and assessing violence and mental health disorders in a cohort of inner city HIV-positive youth between 1998-2006. AIDS Patient Care STDS. 2009;23:469-475.
21. Belzer ME, Fuchs DN, Luftman GS, et al. Antiretroviral adherence issues among HIV-positive adolescents and young adults. J Adolesc Health. 1999;25:316-319. (Pubitemid 29495864)
22. Martinez J, Bell D, Dodds S, et al. Transitioning youths into care: linking identified HIV-infected youth at outreach sites in the community to hospital-based clinics and or community-based health centers. J Adolesc Health. 2003;33:23-30. (Pubitemid 36918441)
23. Futterman DC. HIV and AIDS in adolescents. Adolesc Med Clin. 2004; 15:369-391. (Pubitemid 38900785)
24. Weintrob AC, Fieberg AM, Agan BK, et al. Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART. J Acquir Immune Defic Syndr. 2008;49:40-47.
25. Reisner SL, Mimiaga MJ, Skeer M, et al. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med. 2009;17:14-25.
26. Israelski D, Gore-Felton C, Power R, et al. Sociodemographic characteristics associated with medical appointment adherence among HIVseropositive patients seeking treatment in a county outpatient facility. Prev Med. 2001;33:470-475. (Pubitemid 33035790)
27. Comulada WS, Swendeman DT, Rotheram-Borus MJ, et al. Use of HAART among young people living with HIV. Am J Health Behav. 2003;27:389-400. (Pubitemid 37123465)
28. Murphy DA, Wilson CM, Durako SJ, et al. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 2001;13:27-40. (Pubitemid 32125499)
29. Becker SL, Dezii CM, Burtcel B, et al. Young HIV-infected adults are at greater risk for medication nonadherence. MedGenMed. 2002;4:21.
30. Dodds S, Blakley T, Lizzotte JM, et al. Retention, adherence, and compliance: special needs of HIV-infected adolescent girls and young women. J Adolesc Health. 2003;33:39-45. (Pubitemid 36918443)
31. Hosek SG, Harper GW, Domanico R. Predictors of medication adherence among HIV-infected youth. Psychol Health Med. 2005;10: 166-179. (Pubitemid 40663640)
32. Rao D, Kekwaletswe TC, Hosek S, et al. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19:28-33. (Pubitemid 44852407)
33. Williams PL, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006;118:e1745-e1757. (Pubitemid 46397550)
34. Donenberg GR, Pao M. Youths and HIV/AIDS: psychiatry's role in a changing epidemic. J Am Acad Child Adolesc Psychiatry. 2005;44: 728-747. (Pubitemid 41026277)
35. Mellins CA, Brackis-Cott E, Leu CS, et al. Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters. J Child Psychol Psychiatry. 2009;50:1131-1138.
36. Pao M, Lyon M, D'Angelo LJ, et al. Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000;154:240-244. (Pubitemid 30131903)
37. Tylee A, Haller DM, Graham T, et al. Youth-friendly primary care services: how are we doing and what more needs to be done? Lancet. 2007; 369:1565-1573. (Pubitemid 46670279)